Adenosine acts as a chemoprotective agent by stimulating G-CSF production: A role for A1 and A3 adenosine receptors

Journal of Cellular Physiology

Volumn 183, Issue 3, 2000, Pages 393-398

  Fishman, Pnina ^a,b   Bar Yehuda, Sara ^a   Farbstein, Tamar ^a   Barer, Faina ^a   Ohana, Gil ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,4 TRIAZOLE DERIVATIVE; 3,7 DIMETHYL 1 PROPARGYLXANTHINE; 6 N CYCLOPENTYLADENOSINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; 9 CHLORO 2 (2 FURYL) 5 PHENYLACETYLAMINO 1,2,4 TRIAZOLO[1,5 C]QUINAZOLINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; GRANULOCYTE COLONY STIMULATING FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CANCER CHEMOTHERAPY; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADENOSINE; ANIMALS; BONE MARROW CELLS; CELL CYCLE; CELL DIVISION; CELLS, CULTURED; CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; QUINAZOLINES; RECEPTOR, ADENOSINE A3; RECEPTORS, PURINERGIC P1; THEOBROMINE; TRIAZOLES; XANTHINES;

EID: 0034099041     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(200006)183:3<393::AID-JCP12>3.0.CO;2-G     Document Type: Article

References (34)

1. 2+ elevation, and K channel activity in Jurkat T cells. Cell Immunol 128:385-389.
2. Belardinelli L, Linden J, Berne RM. 1989. The cardiac effects of adenosine. Prog Cardiovasc Dis 32:73-97.
3. Bouma MG, Stad RK, van den Wildenberg FAJM, Buurman WA. 1994. Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J Immunol 153:4159-4168.
4. Clarke B, Coupe M. 1989. Adenosine: cellular mechanisms, pathophysiological roles and clinical applications. Int J Cardiol 23:1-10.
5. Collis MG. 1989. The vasodilator role of adenosine. Pharmacol Ther 41:143-162.
6. Cronstein BN, Levin RI, Philips M, Hirschhorn R, Abramson SB, Weissmann G. 1992. Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors. J Immunol 148:2201-2206.
7. Derigs HG, Reifel-Miller A, Kaushansky K, Hromas RA, Boswell HS. 1994. Granulocyte-macrophage colony-stimulating factor expression is regulated at transcriptional and posttranscriptional levels in a murine bone marrow stromal cell line. Exp Hematol 22:924-932.
8. Djaldetti M, Sredni B, Zigelman R, Verber M, Fishman P. 1996. Muscle cells secrete a low molecular weight factor with anti-cancerous activity. Clin Exp Metastasis 14:189-196.
9. 2B receptors. Circulation 96:2656-2666.
10. Epstein J, Preisler HD. 1984. Protection of normal hematopoietic stem cells from the toxicity of purine base analogs: in vivo application. Cancer Treat Rep 68:1153-1156.
11. Fishman P, Bar-Yehuda S, Wagman L. 1998. Adenosine and other low molecular weight factors released by muscle cells inhibit tumor cell growth: possible explanation for the rarity of metastases in muscle. Cancer Res 58:3181-3187.
12. Gilbertsen RB. 1987. Adenosine and adenosine receptors in immune function. Minireview and meeting report. Agents Actions 22:91-98.
13. Ikebuchi K, Ihle JN, Hirai Y, Wong GG, Clark SC, Ogawa M. 1988. Synergistic factors for stem cell proliferation: further studies of the target stem cells and the mechanism of stimulation by interleukin-1, interleukin-6, and granulocyte colony-stimulating factor. Blood 72:2007-2014.
14. Itoh Y, Ikebuchi K, Hirashima K. 1992. Interleukin-3 and granulocyte colony-stimulating factor as survival factors in murine hematopoietic stem cells in vitro. Int J Hematol 55:139-145.
15. Jackson RC, Morris HP, Weber G. 1978. Adenosine deaminase and adenosine kinase in rat hepatomas and kidney tumors. Br J Cancer 37:701-713.
16. Kitabayashi A, Hirokawa M, Hatano Y, Lee M, Kuroki J, Niitsu H, Miura AB. 1995. Granulocyte colony-stimulating factor downregulates allogeneic immune responses by posttranscriptional inhibition of tumor necrosis factor-alpha production. Blood 86:2220-2227.
17. Krishan A. 1975. Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J Cell Biol 66:188-193.
18. Kurland JI, Hadden JW, Moore MAS. 1977. Role of cyclic nucleotides in the proliferation of committed granulocyte-macrophage progenitor cells. Cancer Res 37:4534-4538.
19. Lee AW. 1999. Synergistic activation of mitogen-activated protein kinase by cyclic AMP and myeloid growth factors opposes cyclic AMP's growth-inhibitory effects. Blood 93:537-553.
20. Linden J. 1991. Structure and function of A1 adenosine receptors. FASEB J 5:2668-2676.
21. 3H] thymidine incorporation into macrophages. Cell Immunol 89:427-438.
22. Nilsson J, Olsson AG. 1984. Prostaglandin E1 inhibits DNA synthesis in arterial smooth muscle cells stimulated with platelet-derived growth factor. Atherosclerosis 53:77-82.
23. Parmely MJ, Zhou WW, Edwards CK, Borcherding DR, Silverstein R, Morrison DC. 1993. Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-α production and protect mice against endotoxin challenge. J Immunol 151:389-396.
24. Pastan IH, Johnson GS, Anderson WB. 1975. Role of cyclic nucleotides in growth control. Annu Rev Biochem 44:491-522.
25. Patil RR, Borch RF. 1995. Granulocyte-macrophage colony-stimulating factor expression by human fibroblasts in both upregulated and subsequently downregulated by interleukin-1. Blood 85:80-86.
26. Pospisil M, Hofer M, Netikova J, Pipalova I, Vacek A, Bartonickova A, Volenec K. 1993. Elevation of extracellular adenosine induces radioprotective effects in mice. Radiat Res 134:323-330.
27. Pospisil M, Hofer M, Znojil V, Vacha J, Netlkova J, Hola J. 1995. Synergistic effect of granulocyte colony-stimulating factor and drugs elevating extracellular adenosine on neutrophil production in mice. Blood 86:3692-3697.
28. Pospisil M, Hofer M, Znojil V, Netikova J, Vacha J, Hola J, Vacek A. 1998. Granulocyte colony-stimulating factor and drugs elevating extracellular adenosine synergize to enhance haematopoietic reconstitution in irradiated mice. Eur J Haematol 60:172-180.
29. Robson RL, Westwick J, Brown Z. 1995. Interleukin-1-induced IL-8 and IL-6 gene expression and production in human mesangial cells is differentially regulated by cAMP. Kidney Int 48:1767-1777.
30. Soderback U, Sollevi A, Wallen VH, Larsson PT, Hjemdahl P. 1991. Anti-aggregatory effects of physiological concentrations of adenosine in human whole blood as assessed by filtragometry. Clin Sci 81:691-694.
31. Stiles GL. 1990. Adenosine receptors and beyond: molecular mechanisms of physiological regulation. Clin Res 38:10-18.
32. Wagner DR, Combes A, McTiernan C, Sanders VJ, Lemster B, Feldman AM. 1998. Adenosine inhibits lipopolysaccharide-induced cardiac expression of tumor necrosis factor-α. Circ Res 82:47-56.
33. kip1 in G-CSF-treated NFS-60 cells. Biochem Biophys Res Commun 224:10-16.
34. Wilson NJ, Jaworowski A, Ward AC, Hamilton JA. 1998. cAMP Enhances CSF-1 induced ERK activity and c-fos mRNA expression via a MEK-dependent and ras-independent mechanism in macrophages. Biochem Biophys Res Commun 244:475-483.